LINQ II Insertable Cardiac Monitor vs VX1
AI Verdict
Choose LINQ II Insertable Cardiac Monitor if…
Choose the Medtronic LINQ II if you require long-term, continuous monitoring for the diagnosis of infrequent or suspected cardiac arrhythmias, such as unexplained syncope or cryptogenic stroke. Its AI-powered accuracy and extended battery life of up to 4.5 years make it ideal for patients needing prolonged, discreet heart rhythm surveillance.
View LINQ II Insertable Cardiac Monitor →Choose VX1 if…
Choose Volta Medical's VX1 if you are an electrophysiologist seeking real-time AI guidance during atrial fibrillation or atrial tachycardia ablation procedures. This FDA-cleared software assists in precisely identifying dispersed electrograms, aiming to enhance procedural efficacy, reduce variability, and standardize outcomes during complex ablations.
View VX1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | LINQ II Insertable Cardiac Monitor | VX1 |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Subcutaneous implant with remote monitoring via mobile app or home communicator. | Software integrated with existing electrophysiology (EP) lab mapping and recording systems. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
LINQ II Insertable Cardiac MonitorTool A offers broader usability with patient-facing mobile apps and remote programming for clinicians, making long-term monitoring more accessible and less disruptive for patients. In contrast, Tool B's usability is highly specialized for electrophysiologists within the EP lab during a specific procedure, which is a narrower scope of interaction.
Clinical Value
LINQ II Insertable Cardiac MonitorTool A provides significant long-term diagnostic value for a broad patient population, including pediatric patients, with proven AI-enhanced accuracy in reducing false alerts by over 91%. While Tool B offers crucial real-time guidance during complex ablation procedures, Tool A's impact is broader and sustained over a longer period for a larger patient base.
Pricing & Value
TieBoth tools have non-transparent pricing models, requiring direct contact for quotes, and neither offers a free trial. While Tool A explicitly states HIPAA compliance, Tool B's company website indicates a commitment to compliance with applicable laws and regulations, including data protection. Without specific pricing or detailed cost-benefit analyses, it is difficult to determine a clear winner in terms of pricing and value.
Enterprise Readiness
LINQ II Insertable Cardiac MonitorTool A demonstrates superior enterprise readiness with explicit HIPAA compliance, a hybrid deployment model, and a proven track record with over a million patients globally through an established company. While Tool B is FDA-cleared and integrates into existing EP lab infrastructure, its explicit HIPAA compliance and broader enterprise adoption details are less transparent compared to Tool A.
Innovation
TieBoth tools represent significant innovation in their respective domains. Tool A innovates in long-term diagnostic monitoring with advanced AI for accuracy and remote management, including a novel manufacturing process. Tool B's real-time AI guidance during complex ablation procedures is groundbreaking, being the first FDA-cleared AI tool in interventional cardiac electrophysiology, aiming to standardize highly operator-dependent procedures. Therefore, both are highly innovative in their distinct applications.
Support & Docs
LINQ II Insertable Cardiac MonitorMedtronic, as a global leader in medical technology, offers a highly extensive and well-established support infrastructure, including comprehensive documentation, dedicated patient services, and technical support for clinicians. While Volta Medical provides user manuals and clinical evidence, the breadth and depth of its support ecosystem are unlikely to match that of a large, long-standing company like Medtronic.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | LINQ II Insertable Cardiac Monitor | VX1 |
|---|---|---|
| Name | LINQ II Insertable Cardiac Monitor | VX1 |
| Company | Medtronic | Volta Medical |
| Description | The Medtronic LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias. | Volta Medical's VX1 is an FDA-cleared AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. |
| Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI, Surgical AI |
| Specialties | Cardiology | Cardiology |
| Key Features | AccuRhythmu2122 AI algorithms for enhanced accuracy, Remote programming capability, Up to 4.5 years of continuous monitoring, MRI compatibility (1.5 and 3.0T), MyCareLink Heartu2122 mobile app for data transmission, MyCareLink Relayu2122 home communicator option, Innovative PVC detection algorithm, Pediatric indication (ages 2+) | AI-guided real-time identification of dispersed electrograms (EGMs), Assists cardiologists during AFib and atrial tachycardia ablation procedures, Analyzes 3D anatomical and electrical maps of human atria, Compatible with most EP recording, 3D navigation systems, and mapping catheters, Designed to reduce inter-operator variability and standardize outcomes, Provides cycle length estimation from electrograms, Booster mode for increased sensitivity during AT or slow AF |
Videos
Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and VX1.